A two-part, single- and two-arm randomized, open-label study to evaluate the safety, tolerability and pharmacokinetics and efficacy of KRP203 in subjects undergoing allogeneic hematopoietic cell transplantation for hematological malignancies

by | Apr 4, 2022 | Exploring Mocravimod Key Research Highlights

https://priothera.com/a-two-part-single-and-two-arm-randomized-open-label-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-and-efficacy-of-krp203-in-subjects-undergoing-allogeneic-hematopoietic-cell-trans/